NewLink Genetics Corporation (NASDAQ:NLNK)
| CAPS Rating |
|
|---|
NLNK
VS S&P 500 (SPY)
NLNK News and Commentary
- Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 2 – SeekingAlpha
- An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABP – 247wallst
- Taking An Early Look at 2012 ASCO Biotech/Cancer Stocks (DNDN, LLY, ARIA, ARRY, BVTI, ABPI, CLDX, CY – 247wallst
- Cancer Drug Developer NewLink Genetics Gets Push From Analysts – Minyanville
How do you think NLNK will perform against the market?
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
Powered by: CAPSAll Players
9
Outperform
5
Underperform
All-Star Players
4
Outperform
3
Underperform
Wall Street
3
Outperform
0
Underperform
RSS Headlines
Fool UK
